Please ensure Javascript is enabled for purposes of website accessibility
BIOTE PROVIDER
Map Marker4889 Golden Parkway Suite 110, Buford, GA, 30518
Certified Provider

BIOTE PROVIDER

Advanced Regenerative Therapy

Buford GA 30518 Hormone Replacement Therapy
Specialty: PHYSICIAN ASSISTANT
At This Location: PA
Serving: Women & Men
Nutraceuticals: Yes

Every day, millions of people experience a hormone imbalance. If you suffer from fatigue, weight gain, low libido, and moodiness, this may indicate you may have a hormone imbalance. Now, there’s help. Your Biote Certified Provider in Buford GA 30518 specializes in hormone optimization to help these and other symptoms of aging with personalized care plans and precision treatments to help you age healthier.

The Biote Method of Hormone Replacement Therapy is offered by us as your Certified Biote Provider in Buford GA 30518. The Biote Method of bioidentical hormone replacement therapy (BHRT) may help many men and women look and feel their best with hormone optimization. To learn how the Biote Method may be able to address specific health issues by restoring hormones to their optimal level, reach out to us and schedule a consultation today.

Allen Meglin, MD

Dr. Allen Meglin was awarded an MD by the University of Pittsburgh School of Medicine. While there the Alpha Omega Alpha honor society inducted Dr. Meglin into membership. He did a surgical internship and a diagnostic radiology residency at Walter Reed Army Medical Center, as well as a fellowship in interventional radiology at the Johns Hopkins hospital. Dr. Meglin rose to chief of interventional radiology at Walter Reed, a position he held for 5 years before going into private practice. He has published several scientific papers, book chapters, and co-authored a text on non-vascular interventional procedures. He is a distinguished reviewer for the Journal of Vascular and Interventional Radiology.

He is an invited lecturer, speaking on minimally invasive procedures and regenerative medicine. Dr. Meglin currently conducts IRB-approved research on PRP as a tissue adhesive. He has been a primary investigator in several FDA trials and has ongoing FDA-approved trials treating COVID-19 patients with regenerative medicinal compounds. He holds four medical device patents, with a regenerative medicine patent pending. He serves on the board of directors for a clinical-stage biopharmaceutical company.

The community considers Dr. Meglin a doctor’s doctor, with 60-70% of his patients being physicians and nurses. The ABRM considers Dr. Meglin one of only a handful physicians eligible for board certification .

Megan Duncan, PA

.